Home › Funds › Blue Owl Capital Holdings LP › PVLA

Blue Owl Capital Holdings LP position in PVLA

PALVELLA THERAPEUTICS INC NE · Health Care

Blue Owl Capital Holdings LP reported holding 23,003 shares of PVLA (PALVELLA THERAPEUTICS INC NE) in its Q3 2026 13F filing — a position valued at US$3.2M, representing 0.60% of its reported portfolio and ranking #25 among its reported holdings. Blue Owl Capital Holdings LP has disclosed PVLA holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)23.00K sh
Reported value held$3.17M
Portfolio Weight0.60%
First reportedQ4 2024
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Blue Owl Capital Holdings LP's PVLA position evolved

Blue Owl Capital Holdings LP first disclosed a stake in PVLA in Q4 2024 at 250,062 shares (US$3.0M). The position peaked in Q3 2025 at 95,259 shares, worth US$6.0M. Across 8 filings, Blue Owl Capital Holdings LP increased the stake 1 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 23,003 shares valued at US$3.2M — a reduction of -13,256 shares quarter over quarter.. Notable position changes include a 44% trim in Q1 2025 (shares fell 19% over the following quarter), a 58% trim in Q4 2025 (shares rose 19% over the following quarter), a 37% trim in Q3 2026 (shares rose 19% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 250.06K $3.00M New
Q1 2025 140.26K $3.93M Reduce
Q2 2025 125.26K $2.82M Reduce
Q3 2025 95.26K $5.97M Reduce
Q4 2025 40.26K $4.21M Reduce
Q1 2026 31.26K $3.90M Reduce
Q2 2026 36.26K $5.54M Add
Q3 2026 23.00K $3.17M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PVLA and 13F data

PVLA (PALVELLA THERAPEUTICS INC NE) is a Health Care company. 83 other funds we track also report a position in PVLA — the largest reported positions include MONTANOVA CAPITAL, LLC (US$173.5M), Frazier Life Sciences Management, L.P. (US$134.8M), First Light Asset Management, LLC (US$118.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PVLA

All PVLA fund holders →

FAQ

How long has Blue Owl Capital Holdings LP held PVLA?

Blue Owl Capital Holdings LP has disclosed PVLA holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Blue Owl Capital Holdings LP's current position in PVLA?

As of Q3 2026, Blue Owl Capital Holdings LP holds 23.00K shares of PVLA (PALVELLA THERAPEUTICS INC NE), valued at $3.17M, representing 0.60% of its reported portfolio and ranking #25.

Has Blue Owl Capital Holdings LP been buying or selling PVLA?

In the latest 13F filing (Q3 2026), Blue Owl Capital Holdings LP reduced its position in PVLA. The position peaked in Q3 2025 at 95.26K shares.

Which other funds hold PVLA?

Other major institutional holders of PVLA include MONTANOVA CAPITAL, LLC, Frazier Life Sciences Management, L.P., First Light Asset Management, LLC, among 83 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.